Background In the recent era, laparoscopic sleeve gastrectomy (LSG) had emerged as a safe and effective bariatric procedure. Rapid weight loss is associated with deranged cholesterol metabolism in the form of gallstones. Materials and methods This two-center prospective randomized controlled trial had been conducted at Abha Private Hospital, Saudi Arabia, and Ain-Shams University hospitals, Egypt, from May 2016 to June 2017 on 89 post-LSG patients. After block randomization, patients were allocated into either group A (UDCA treatment) or group B (control). UDCA was prescribed as 250 mg twice daily for 12 months or until the development of gallstones. Results A total of 44 patients were included in group A and 45 patients were included in group B. There was no significant difference between both the groups regarding the baseline parameters. Conclusion UDCA is a safe prophylactic measure against gallstones formation and should be integrated into the post-LSG prescription.
Abouzeid, T. A., & Shoka, A. A. (2018). Should we prescribe ursodeoxycholic acid after laparoscopic sleeve gastrectomy? A two-center prospective randomized controlled trial. The Egyptian Journal of Surgery, 37(3), -. doi: 10.4103/ejs.ejs_25_18
MLA
Tarek A.O. Abouzeid; Ahmed A.A. Shoka. "Should we prescribe ursodeoxycholic acid after laparoscopic sleeve gastrectomy? A two-center prospective randomized controlled trial", The Egyptian Journal of Surgery, 37, 3, 2018, -. doi: 10.4103/ejs.ejs_25_18
HARVARD
Abouzeid, T. A., Shoka, A. A. (2018). 'Should we prescribe ursodeoxycholic acid after laparoscopic sleeve gastrectomy? A two-center prospective randomized controlled trial', The Egyptian Journal of Surgery, 37(3), pp. -. doi: 10.4103/ejs.ejs_25_18
VANCOUVER
Abouzeid, T. A., Shoka, A. A. Should we prescribe ursodeoxycholic acid after laparoscopic sleeve gastrectomy? A two-center prospective randomized controlled trial. The Egyptian Journal of Surgery, 2018; 37(3): -. doi: 10.4103/ejs.ejs_25_18
)
View on SCiNiTO